J&J's (JNJ -0.5%) Janssen Pharmaceuticals settles with 36 states and the District of...

|By:, SA News Editor

J&J's (JNJ -0.5%) Janssen Pharmaceuticals settles with 36 states and the District of Columbia regarding allegations related to promotional and marketing practices for its anti-psychotic medication Risperdal. Under the terms of the agreement, the company will pay approximately $181M, with predesignated portions to be paid to each state participating in the settlement.